ArticleThe International journal on drug policy2026
Self-reported cannabis use following cash transfer: Estimating the short-term impacts of the Alaska Permanent Fund Dividend.
Article in The International journal on drug policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimsResearchers have hypothesized that cash transfers affect substance use through two competing pathways: relieving financial strain which could reduce use, or expanding spendable income, which could increase use. We tested whether payments from the Permanent Fund Dividend (PFD)-a near universal annual payment to residents of Alaska-was associated with changes in post-PFD disbursement cannabis use in Alaska versus comparison jurisdictions.
methodsWe used data from the Behavioral Risk Factor Surveillance System (BRFSS) cannabis module in Alaska (2016, 2017, 2020, 2021) and other jurisdictions with recreational cannabis laws. Outcomes included past-month cannabis use (any), daily/near daily use, and days of use. Survey-weighted regression models compared each cannabis outcome during the post-PFD disbursement window versus other timeframes among Alaska residents relative to contemporaneous changes among residents of comparison jurisdictions.
resultsCannabis use was higher among Alaska residents than in comparison jurisdictions with similar cannabis laws, both during and outside of the PFD disbursement window. In adjusted models, PFD disbursement was not meaningfully associated with changes in any past-month cannabis use (Odds Ratio [OR]: 0.96; 95% Confidence Interval [CI] 0.66-1.41) or daily/near daily use (OR: 1.07; CI: 0.65-1.76). Similarly, no changes in past-month days of cannabis use (Count Ratio [CR]: 1.01; CI: 0.70-1.45) were observed following disbursement.
conclusionsWe found no evidence that disbursement of the PFD was associated with either increases or decreases in short-term cannabis use in Alaska. Whether these null findings persist for other substances, or under different program structures, remains an important question for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.